Custom Search

FDA Information

Fludarabine is FDA approved for the treatment of chronic lymphocytic leukemia that has stopped responding, or never responded, to previous therapies. It may also be used as therapy for patients with non-Hodgkin’s lymphoma or acute leukemia that has stopped responding to standard therapies.

Fludarabine has been available for use since the early 1990s. Please visit the official site of the FDA if you are interested in finding further information regarding this medication.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose

Use of this site is subject to the following terms of use